Vaxent Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.94M

  • Investors
  • 3

Vaxent General Information

Description

Developer of sub-unit vaccines designed to fight against group A streptococcus that causes pharyngitis and strep throat in children. The company's vaccines are used to treat various infectious diseases that have been tested in early-stage human clinical trials to advance its lead product in clinical testing, enabling patients to develop immunity against infectious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Memphis, TN 37501
  • United States
+1 (901)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Memphis, TN 37501
  • United States
+1 (901)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaxent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 20-Jul-2017 $3.94M Completed Clinical Trials - General
4. Debt - General 23-Mar-2015 Completed Clinical Trials - General
3. Early Stage VC 06-Nov-2009 Completed Clinical Trials - General
2. Early Stage VC (Series A) 24-Jun-2008 $50K $50K Completed Clinical Trials - General
1. Accelerator/Incubator 01-Apr-2008 Completed Startup
To view Vaxent’s complete valuation and funding history, request access »

Vaxent Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute for Allergy and Infectious Disease Government
Innova Memphis Venture Capital Minority
Memphis Bioworks Foundation Not-For-Profit Venture Capital
To view Vaxent’s complete investors history, request access »

Ready to get started?

Request a free trial

Vaxent FAQs

  • When was Vaxent founded?

    Vaxent was founded in 2008.

  • Where is Vaxent headquartered?

    Vaxent is headquartered in Memphis, TN.

  • What industry is Vaxent in?

    Vaxent’s primary industry is Drug Discovery.

  • Is Vaxent a private or public company?

    Vaxent is a Private company.

  • What is Vaxent’s current revenue?

    The current revenue for Vaxent is .

  • How much funding has Vaxent raised over time?

    Vaxent has raised $50K.

  • Who are Vaxent’s investors?

    National Institute for Allergy and Infectious Disease, Innova Memphis, and Memphis Bioworks Foundation have invested in Vaxent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »